Cargando…
Tiotropium in the add-on treatment of asthma in adults: clinical trial evidence and experience
Asthma is a chronic inflammatory airway disease, and its treatment is frequently challenging despite detailed national and international guidelines. While basic anti-inflammatory therapy usually consists of inhaled corticosteroids in doses adapted to the asthma severity, add-on treatment with bronch...
Autor principal: | Vogelberg, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5933593/ https://www.ncbi.nlm.nih.gov/pubmed/27612491 http://dx.doi.org/10.1177/1753465816662571 |
Ejemplares similares
-
Tiotropium add-on therapy is safe and reduces seasonal worsening in paediatric asthma patients
por: Vogelberg, Christian, et al.
Publicado: (2019) -
Tiotropium as an Add-on Treatment Option for Severe Uncontrolled Asthma in Preschool Patients
por: Zielen, Stefan, et al.
Publicado: (2021) -
Asthma exacerbations and worsenings in patients aged 1–75 years with add-on tiotropium treatment
por: Mark FitzGerald, J., et al.
Publicado: (2020) -
Tiotropium in asthma: what is the evidence and how does it fit in?
por: Halpin, David M. G.
Publicado: (2016) -
The evidence on tiotropium bromide in asthma: from the rationale to the bedside
por: Radovanovic, Dejan, et al.
Publicado: (2017)